About XIEYI Media

Since 2013, based on the "Highland of China's Novel drug thought", TONACEA has started to build a new media matrix, and has carried out multi-level reports on frontier technology, policies and regulations, capital markets, industrial transformation, innovative figures and other bio-innovation related fields. At present, TONACEA continues to serve more than 500 customers.

 

On wechat, TONACEA accounts have accumulated more than 300,000 subscribers, mainly including leaders of government, parks, listed companies, innovative pharmaceutical enterprises, investment institutions, and front-line practitioners. In addition, TONACEA has entered community platforms such as Snowball, Zhihu and Weibo. TONACEA's brand exposure has exceeded 24 million.

图片名称
图片名称

TONACEA

Hot Event Analysis

Subdivision Track Count

Interview of Industry Figures

Think Tank View Output

图片名称
图片名称

XIEYI Release

Enterprise Dynamics

Personnel Change

Product Progress

Policy Release

图片名称
图片名称

TONACEA Biotech

Interpretation of Frontier Achievements

Introduction to Basic Scientific Research

图片名称
图片名称

TONACEA Micro Service

Industrial Activity Information

Theme Live Preview

Recommendation

When CAR-T Crosses into Autoimmune Diseases

Risk Definition

RNA Drugs: Has the "Golden Narrative" Collapsed?

The Price of "Silence"

At 27, AstraZeneca Has a Touch of Melancholy

Finding the Next Growth Curve

Sweeping, clearing, and discounting: The pricing paradox of innovative drugs in China

A billion-dollar BD cannot buy recognition in the secondary market

The 18D reform of the Hong Kong stock market is coming, who can catch this wave of capital dividends?

Is the IPO going to change in Hong Kong?

China Biotech 2026: America Against America(Part 3)

Here Come the Clubs

Contact us

图片名称

Contribution and Writing articles

Yu Jing:15521120587

图片名称
图片名称

Media Release

Li Chun:19910611152

图片名称